This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
July 12, 2012 /PRNewswire-Asia-FirstCall/ --
Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in
China, today announced that it has obtained software copyrights from the National Copyright Administration of PRC for four of its proprietary technologies, including:
Analysis and Monitoring Software of Adsorption Tower Oxygen Generation Process;
Dehaier Homecare CPAP Controlling Software;
Ventilator of CPAP Controlling Software; and
Air Compressor Controlling Software.
These copyrights have been approved for 50 years. In addition to providing the Company protection in the event of infringement, the software copyright registration is essential to the Company's identification as a "software enterprise" or a "high-technology enterprise." These statuses are important to Dehaier, as they allow the Company to receive preferential government treatment, such as subsidies and tax benefits.
Ping Chen, CEO of Dehaier, commented, "We continue to focus on developing quality homecare medical devices, which rely on precise IT and software applications that Dehaier develops internally. These copyrights are important in protecting the technology that Dehaier is developing, especially as we introduce more products to market. We also expect to benefit from the favorable policies and subsidies from
China's government as a result of our treatment as a hi-tech enterprise. With the addition of these copyrights, we have two utility model patents, four design patents and nine software copyrights. We will continue to protect our intellectual property portfolio in unison with strengthening our R&D capabilities, increasing our brand recognition, and gaining market share."
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (
Italy), Welch Allyn (
USA), HEYER (
Germany), Timesco (UK), eVent Medical (US) and JMS (
Japan). Dehaier's technology is based on six patents, nine software copyrights and proprietary technology. More information may be found at